drug firm glaxosmithkline has applied for a licence from the european medicines agency -lrb- ema -rrb- for the rts , s vaccine .
the vaccine , which has just completed the final stages of testing , could make a ` substantial contribution ' to controlling the disease .
the news is significant because rts is the first malaria vaccine to reach advanced trials .